{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:16:53Z","timestamp":1761513413632,"version":"build-2065373602"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.eplepsyres.2014.01.012","type":"journal-article","created":{"date-parts":[[2014,1,31]],"date-time":"2014-01-31T18:15:25Z","timestamp":1391192125000},"page":"390-395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Positive effect of calcitonin on the seizures induced by pentylenetetrazole in rats"],"prefix":"10.1016","volume":"108","author":[{"given":"Durdane","family":"Aksoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volkan","family":"Solmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oytun","family":"Erbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.eplepsyres.2014.01.012_bib0005","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1111\/j.1528-1167.2005.00337.x","article-title":"Levetiracetam efficacy in epileptic syndromes with continuous spikes and wavess during slow sleep: experience in 12 cases","volume":"46","author":"Aeby","year":"2005","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.eplepsyres.2014.01.012_bib0010","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1248\/bpb.b12-00887","article-title":"Salmon calcitonin reduces oxaliplatin-induced cold and mechanical allodynia in rats","volume":"36","author":"Aoki","year":"2013","journal-title":"Biol. Pharm. Bull."},{"issue":"May (5 Suppl.)","key":"10.1016\/j.eplepsyres.2014.01.012_bib0015","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S8756-3282(02)00702-0","article-title":"Calcitonin in reflex sympathetic dystrophy syndrome and other painful conditions","volume":"30","author":"Appelboom","year":"2002","journal-title":"Bone"},{"issue":"15","key":"10.1016\/j.eplepsyres.2014.01.012_bib0020","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.2174\/1381612054021006","article-title":"Ion channels and epilepsy","volume":"11","author":"Armijo","year":"2005","journal-title":"Curr. Pharm. Des."},{"issue":"May (5 Suppl.)","key":"10.1016\/j.eplepsyres.2014.01.012_bib0025","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S8756-3282(02)00701-9","article-title":"Possible mechanisms of the analgesic action of calcitonin","volume":"30","author":"Azria","year":"2002","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.eplepsyres.2014.01.012_bib0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3988\/jcn.2012.8.1.65","article-title":"May long term oxcarbazepine treatment be lead to secondary hyperparathyroidism?","volume":"8","author":"Babacan","year":"2012","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.eplepsyres.2014.01.012_bib0035","first-page":"489","article-title":"Neuropeptides: anticonvulsant and convulsant mechanisms in epileptic model systems and in humans","volume":"44","author":"Bajorek","year":"1986","journal-title":"Adv. Neurol."},{"issue":"Suppl. 7","key":"10.1016\/j.eplepsyres.2014.01.012_bib0040","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1528-1167.2012.03712.x","article-title":"Why are antiepileptic drugs used for nonepileptic conditions?","volume":"53","author":"Bialer","year":"2012","journal-title":"Epilepsia"},{"issue":"Suppl. 9","key":"10.1016\/j.eplepsyres.2014.01.012_bib0045","first-page":"21","article-title":"Cellular and network mechanisms of spike-wave seizures","volume":"46","author":"Blumenfeld","year":"2012","journal-title":"Epilepsia"},{"issue":"Suppl. 4","key":"10.1016\/j.eplepsyres.2014.01.012_bib0050","first-page":"51","article-title":"Emerging insights into mechanisms of epilepsy: implications for new antiepileptic drug development","volume":"35","author":"Dichter","year":"1994","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.eplepsyres.2014.01.012_bib0055","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jpain.2006.10.001","article-title":"Sodium channel blockade may contribute to the analgesic efficacy of antidepressants","volume":"8","author":"Dick","year":"2007","journal-title":"J. Pain"},{"issue":"November","key":"10.1016\/j.eplepsyres.2014.01.012_bib0060","article-title":"Neuropeptides in epilepsy","volume":"19","author":"Dobolyi","year":"2013","journal-title":"Curr. Med. Chem."},{"issue":"4","key":"10.1016\/j.eplepsyres.2014.01.012_bib0065","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1213\/ane.0b013e3181685014","article-title":"Chronic phantom limb pain: the effects of calcitonin, ketamine, and their combination on pain and sensory thresholds","volume":"106","author":"Eichenberger","year":"2008","journal-title":"Anesth. Analg."},{"issue":"February","key":"10.1016\/j.eplepsyres.2014.01.012_bib0070","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.peptides.2012.12.003","article-title":"Oxytocin inhibits pentylentetrazol-induced seizures in the rat","volume":"40","author":"Erbas","year":"2013","journal-title":"Peptides"},{"issue":"1\u20132","key":"10.1016\/j.eplepsyres.2014.01.012_bib0075","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0304-3959(03)00173-8","article-title":"Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C","volume":"105","author":"Fehrenbacher","year":"2003","journal-title":"Pain"},{"issue":"1\u20132","key":"10.1016\/j.eplepsyres.2014.01.012_bib0260","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.pain.2004.01.029","article-title":"Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy","volume":"109","author":"Flatters","year":"2004","journal-title":"Pain"},{"issue":"5 (Suppl. 15)","key":"10.1016\/j.eplepsyres.2014.01.012_bib0080","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/sonc.2002.35525","article-title":"Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures","volume":"29","author":"Gamelin","year":"2002","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.eplepsyres.2014.01.012_bib0085","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1592\/phco.20.12.191S.35250","article-title":"Antiepileptic drug treatment: outcomes and adherence","volume":"20","author":"Garnett","year":"2000","journal-title":"Pharmacotherapy"},{"issue":"10","key":"10.1016\/j.eplepsyres.2014.01.012_bib0090","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1074\/jbc.271.10.5768","article-title":"The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel","volume":"271","author":"Gee","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.eplepsyres.2014.01.012_bib0095","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ceca.2007.05.019","article-title":"Feedback mechanisms in the regulation of intracellular calcium ([Ca2+]i) in the peripheral nociceptive system: role of TRPV-1 and pain related receptors","volume":"43","author":"Hagenacker","year":"2008","journal-title":"Cell Calcium"},{"issue":"1\u20132","key":"10.1016\/j.eplepsyres.2014.01.012_bib0100","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.brainresbull.2011.02.006","article-title":"Additive inhibitory effects of calcitonin and capsaicin on voltage activated calcium channel currents in nociceptive neurones of rat","volume":"85","author":"Hagenacker","year":"2011","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.eplepsyres.2014.01.012_bib0105","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2147\/IJWH.S24776","article-title":"Oral calcitonin","volume":"4","author":"Hamdy","year":"2012","journal-title":"Int. J. Womens Health"},{"issue":"4","key":"10.1016\/j.eplepsyres.2014.01.012_bib0110","doi-asserted-by":"crossref","first-page":"223","DOI":"10.33588\/rn.4204.2006038","article-title":"Pregabalin: new therapeutic contributions of calcium channel alpha2delta protein ligands on epilepsy and neuropathic pain","volume":"42","author":"Horga de la Parte","year":"2006","journal-title":"Rev. Neurol."},{"issue":"1","key":"10.1016\/j.eplepsyres.2014.01.012_bib0115","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0006-8993(96)01496-5","article-title":"L-NAME inhibits pentylenetetrazole and strychnine-induced seizures in mice","volume":"753","author":"Kaputlu","year":"1997","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.eplepsyres.2014.01.012_bib0120","first-page":"75","article-title":"The effects of calcitonin-gene related peptide (CGRP) on strychnine-induced seizures","volume":"5","author":"Kov\u00e1cs","year":"1997","journal-title":"Neurobiology (Bp)"},{"issue":"6.","key":"10.1016\/j.eplepsyres.2014.01.012_bib0125","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.npep.2013.10.015","article-title":"Neuropeptides in epilepsy","volume":"47","author":"Kovac","year":"2013","journal-title":"Neuropeptides"},{"issue":"1","key":"10.1016\/j.eplepsyres.2014.01.012_bib0130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0022-3476(87)80342-6","article-title":"Monomeric serum calcitonin and bone turnover during anticonvulsant treatment and in congenital hypothyroidism","volume":"111","author":"Kruse","year":"1987","journal-title":"J. Pediatr."},{"issue":"7306","key":"10.1016\/j.eplepsyres.2014.01.012_bib0135","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0140-6736(63)90224-1","article-title":"Further evidence for calciton\u0131n. A rapid-acting hormone which lowers plasma-calcium","volume":"2","author":"Kumar","year":"1963","journal-title":"Lancet"},{"issue":"May (5 Suppl.)","key":"10.1016\/j.eplepsyres.2014.01.012_bib0140","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S8756-3282(02)00714-7","article-title":"Analgesic effects of calcitonin","volume":"30","author":"Lyritis","year":"2002","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.eplepsyres.2014.01.012_bib0145","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0014-2999(90)90084-J","article-title":"Effect of anticonvulsant treatment on kainic acid-induced increases in peptide levels","volume":"181","author":"Marksteiner","year":"1990","journal-title":"Eur. J. Pharmacol."},{"issue":"June","key":"10.1016\/j.eplepsyres.2014.01.012_bib0150","volume":"14","author":"Martinotti","year":"2013","journal-title":"Curr. Pharm. Des."},{"issue":"4","key":"10.1016\/j.eplepsyres.2014.01.012_bib0155","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1528-1167.2012.03423.x","article-title":"Ghrelin: an emerging new anticonvulsant neuropeptide","volume":"53","author":"Portelli","year":"2012","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.eplepsyres.2014.01.012_bib0160","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.mehy.2008.01.018","article-title":"Could calcitonin be a useful therapeutic agent for trigeminal neuralgia?","volume":"71","author":"Qin","year":"2008","journal-title":"Med. Hypotheses"},{"issue":"Suppl. 6","key":"10.1016\/j.eplepsyres.2014.01.012_bib0165","first-page":"60","article-title":"Effects of antiepileptic drugs on hormones","volume":"32","author":"Ramsay","year":"1991","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.eplepsyres.2014.01.012_bib0170","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1159\/000116854","article-title":"Long-term influence of anticonvulsant agents on calcitonin, parathyroid hormone and osteocalcin","volume":"32","author":"Rico","year":"1992","journal-title":"Eur. Neurol."},{"issue":"4","key":"10.1016\/j.eplepsyres.2014.01.012_bib0175","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1039\/c0np00048e","article-title":"Anticonvulsant neuropeptides as drug leads for neurological diseases","volume":"28","author":"Robertson","year":"2011","journal-title":"Nat. Prod. Rep."},{"issue":"7","key":"10.1016\/j.eplepsyres.2014.01.012_bib0180","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nm1074","article-title":"The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions","volume":"10","author":"Rogawski","year":"2004","journal-title":"Nat. Med."},{"issue":"Suppl. 6","key":"10.1016\/j.eplepsyres.2014.01.012_bib0185","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.0013-9580.2004.455005.x","article-title":"The use of antiepileptic drugs \u2013 principles and practice","volume":"45","author":"Sander","year":"2004","journal-title":"Epilepsia"},{"issue":"January\u2013February (1)","key":"10.1016\/j.eplepsyres.2014.01.012_bib0190","first-page":"47","article-title":"Gabapentin decreases membrane calcium currents in injured as well as in control mammalian primary afferent neurons","volume":"27","author":"Sarantopoulos","year":"2002","journal-title":"Reg. Anesth. Pain Med."},{"issue":"3","key":"10.1016\/j.eplepsyres.2014.01.012_bib0195","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0167-0115(89)90189-4","article-title":"Pronounced increases in brain levels of calcitonin gene-related peptide after kainic acid induced seizures","volume":"26","author":"Saria","year":"1989","journal-title":"Regul. Pept."},{"issue":"1","key":"10.1016\/j.eplepsyres.2014.01.012_bib0200","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1517\/17425255.2013.749239","article-title":"Pharmacokinetic and pharmacodynamic profile of pregabalin and its role in the treatment of epilepsy","volume":"9","author":"Schulze-Bonhage","year":"2013","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"November (11)","key":"10.1016\/j.eplepsyres.2014.01.012_bib0205","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2174\/092986730611220401164504","article-title":"Calcitonin","volume":"6","author":"Sexton","year":"1999","journal-title":"Curr. Med. Chem."},{"issue":"6","key":"10.1016\/j.eplepsyres.2014.01.012_bib0210","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.neuint.2013.02.021","article-title":"Antioxidant activity elicited by low dose of caffeine attenuates pentylenetetrazol-induced seizures and oxidative damage in rats","volume":"62","author":"Souza","year":"2013","journal-title":"Neurochem. Int."},{"issue":"9","key":"10.1016\/j.eplepsyres.2014.01.012_bib0215","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1528-1157.1997.tb01477.x","article-title":"Voltage-activated calcium channels: targets of antiepileptic drug therapy?","volume":"38","author":"Stefani","year":"1997","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.eplepsyres.2014.01.012_bib0220","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/sj.bjp.0704439","article-title":"Gabapentin inhibits high-threshold calcium channel currents in cultured rat dorsal root ganglion neurones","volume":"135","author":"Sutton","year":"2002","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.eplepsyres.2014.01.012_bib0225","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clinthera.2007.01.013","article-title":"Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders","volume":"29","author":"Tassone","year":"2007","journal-title":"Clin. Ther."},{"issue":"2","key":"10.1016\/j.eplepsyres.2014.01.012_bib0230","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/sj.bjp.0705434","article-title":"Potent analgesic effects of anticonvulsants on peripheral thermal nociception in rats","volume":"140","author":"Todorovic","year":"2003","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.eplepsyres.2014.01.012_bib0235","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/cne.10478","article-title":"Ontogeny of calcitonin receptor mRNA and protein in the developing central nervous system of the rat","volume":"456","author":"Tolcos","year":"2003","journal-title":"J. Comp. Neurol."},{"issue":"October (5)","key":"10.1016\/j.eplepsyres.2014.01.012_bib0240","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1177\/0310057X0603400505","article-title":"Salmon calcitonin in the treatment of post herpetic neuralgia","volume":"34","author":"Visser","year":"2006","journal-title":"Anaesth. Intensive Care"},{"issue":"11","key":"10.1016\/j.eplepsyres.2014.01.012_bib0245","first-page":"1147","article-title":"H-magnetic resonance spectroscopy on bilateral thalamus of patients with secondarily generalized tonic\u2013clonic seizures","volume":"37","author":"Wang","year":"2012","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"7","key":"10.1016\/j.eplepsyres.2014.01.012_bib0250","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/sj.bjp.0706407","article-title":"Oxaliplatin induces hyperexcitability at motor and autonomic neuromuscular junctions through effects on voltage-gated sodium channels","volume":"146","author":"Webster","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2014.01.012_bib0255","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0074-7742(06)81006-8","article-title":"Mechanisms of action of antiepileptic drugs","volume":"81","author":"White","year":"2007","journal-title":"Int. Rev. Neurobiol."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121114000254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121114000254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:30:23Z","timestamp":1760275823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121114000254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0920121114000254"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2014.01.012","relation":{},"ISSN":["0920-1211"],"issn-type":[{"type":"print","value":"0920-1211"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Positive effect of calcitonin on the seizures induced by pentylenetetrazole in rats","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2014.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}